1
Home
Companies

Baudax Bio

#8693

Rank

$950.33K

Marketcap

US United States

Country

Baudax Bio
Leadership team

Dr. Geraldine A. Henwood Ph.D. (Pres, CEO & Director)

Ms. Jillian Dilmore (Corp. Controller, Corp. Sec., Interim Principal Financial & Accounting Officer)

Ms. Diane Myers (Sr. VP of Regulatory & Quality)

Products/ Services
Biotechnology, Pharmaceutical, Therapeutics
Number of Employees
50 - 100
Headquarters
Malvern, Pennsylvania, United States
Established
2015
Company Registration
SEC CIK number: 0001780097
Revenue
500K - 2M
Traded as
BXRX
URL
https://www.baudaxbio.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
History

Baudax Bio was founded in 1955 by Dr. Nancy Holtman. Dr. Holtman had a vision to create groundbreaking treatments for women’s health conditions. After painstaking research and development, Baudax Bio has earned a reputation for developing and manufacturing treatments with exceptional safety and efficacy.

Mission
At Baudax Bio, our mission is to develop and deliver innovative therapies that improve health outcomes and enhance the quality of life for women around the world.
Vision
Our vision is to become the world leader in women’s health innovation through creating treatments that provide the highest quality care to patients in need.
Key Team

Dr. Geraldine A. Henwood Ph.D. (Pres, CEO & Director)

Ms. Jillian Dilmore (Corp. Controller, Corp. Sec., Interim Principal Financial & Accounting Officer)

Ms. Diane Myers (Sr. VP of Regulatory & Quality)

Recognition and Awards
Baudax Bio has received numerous industry awards, including the European Pharmaceutical Supply Chain Award and the U.S. Assurance of Quality Award.
References

https://in.investing.com/equities/baudax-bio-inc

https://finance.yahoo.com/quote/BXRX/profile?p=BXRX

https://www.crunchbase.com/organization/baudax-bio

https://companiesmarketcap.com/

https://www.baudaxbio.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Baudax Bio
Leadership team

Dr. Geraldine A. Henwood Ph.D. (Pres, CEO & Director)

Ms. Jillian Dilmore (Corp. Controller, Corp. Sec., Interim Principal Financial & Accounting Officer)

Ms. Diane Myers (Sr. VP of Regulatory & Quality)

Products/ Services
Biotechnology, Pharmaceutical, Therapeutics
Number of Employees
50 - 100
Headquarters
Malvern, Pennsylvania, United States
Established
2015
Company Registration
SEC CIK number: 0001780097
Revenue
500K - 2M
Traded as
BXRX
URL
https://www.baudaxbio.com